(Q36756258)

English

Doping with growth hormone/IGF-1, anabolic steroids or erythropoietin: is there a cancer risk?

scientific article published on 3 February 2007

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed ID

17349798

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17349798%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 December 2019

review article

1 reference

stated in

Europe PubMed Central

title

Doping with growth hormone/IGF-1, anabolic steroids or erythropoietin: is there a cancer risk? (English)

1 reference

stated in

Europe PubMed Central

PubMed ID

17349798

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17349798%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

1

1 reference

stated in

Europe PubMed Central

PubMed ID

17349798

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17349798%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 December 2019

Grazia Graziani

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed ID

17349798

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17349798%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1

Lucio Tentori

1 reference

stated in

Europe PubMed Central

16 August 2017

2

Grazia Graziani

1 reference

stated in

Europe PubMed Central

16 August 2017

3 February 2007

1 reference

stated in

Europe PubMed Central

PubMed ID

17349798

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17349798%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 December 2019

published in

Pharmacological Research

1 reference

stated in

Europe PubMed Central

PubMed ID

17349798

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17349798%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 December 2019

volume

55

1 reference

stated in

Europe PubMed Central

PubMed ID

17349798

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17349798%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 December 2019

issue

5

1 reference

stated in

Europe PubMed Central

PubMed ID

17349798

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17349798%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 December 2019

page(s)

359-369

1 reference

stated in

Europe PubMed Central

PubMed ID

17349798

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17349798%20AND%20SRC:MED&resulttype=core&format=json

(Q36756258)

Doping with growth hormone/IGF-1, anabolic steroids or erythropoietin: is there a cancer risk?

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)